title: Outcomes of Universal Access to Antiretroviral Therapy (ART) in Georgia.
abstract: Since 2004, Georgia achieved universal access to free antiretroviral therapy (ART). A retrospective cohort study was conducted to evaluate the outcomes of Georgia's ART program. The study included adult patients enrolled in the ART program from 2004 through 2009. Of 752 patients, 76% were men, 60% were injection drug users (IDU), 59% had a history of an AIDS-defining illness, and 53% were coinfected with hepatitis C. The median baseline CD4 cell count was 141 cells/mm(3). During followup, 152 (20%) patients died, with the majority of deaths occurring within 12 months of ART initiation. Mortality was associated with advanced immunodeficiency or the presence of incurable disease at baseline. Among patients remaining on treatment, the median CD4 gain was 216 cell/mm(3) and 86% of patients had viral load <400 copies/ml at the last clinical visit. The Georgia ART program has been successful in treating injection drug users infected with HIV.
authors.affiliation: Infectious Diseases, AIDS and Clinical Immunology Research Center (IDACIRC), 16 Al. Kazbegi Avenue, Tbilisi 0160, Georgia.
authors.forename: Tengiz
authors.initials: T
authors.lastname: Tsertsvadze
authors.forename: Nikoloz
authors.initials: N
authors.lastname: Chkhartishvili
authors.forename: Lali
authors.initials: L
authors.lastname: Sharvadze
authors.forename: Natia
authors.initials: N
authors.lastname: Dvali
authors.forename: Otar
authors.initials: O
authors.lastname: Chokoshvili
authors.forename: Pati
authors.initials: P
authors.lastname: Gabunia
authors.forename: Akaki
authors.initials: A
authors.lastname: Abutidze
authors.forename: Kenrad
authors.initials: K
authors.lastname: Nelson
authors.forename: Jack
authors.initials: J
authors.lastname: Dehovitz
authors.forename: Carlos
authors.initials: C
authors.lastname: Del Rio